These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 17846008

  • 1. [Angiogenesis and lung cancer].
    Pérol M, Arpin D.
    Bull Cancer; 2007 Jul; 94 Spec No():S220-31. PubMed ID: 17846008
    [Abstract] [Full Text] [Related]

  • 2. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Langer CJ, Natale RB.
    Semin Oncol; 2005 Dec; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
    [Abstract] [Full Text] [Related]

  • 3. New antiangiogenetic agents and non-small cell lung cancer.
    Gridelli C, Rossi A, Maione P.
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):76-86. PubMed ID: 16843002
    [Abstract] [Full Text] [Related]

  • 4. [The actual place of anti-angiogenesis in non-small cell lung cancer].
    Mennecier B.
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S198-205. PubMed ID: 18235414
    [Abstract] [Full Text] [Related]

  • 5. Multitargeted inhibitors in lung cancer: new clinical data.
    Bar J, Herbst RS, Onn A.
    Clin Lung Cancer; 2008 Oct; 9 Suppl 3():S92-9. PubMed ID: 19419930
    [Abstract] [Full Text] [Related]

  • 6. Antiangiogenic therapy in nonsmall cell lung cancer.
    Gutierrez M, Giaccone G.
    Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting angiogenesis in lung cancer.
    Sandler AB.
    Semin Oncol; 2005 Dec; 32(6 Suppl 10):S16-22. PubMed ID: 16459175
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer.
    Aita M, Fasola G, Defferrari C, Brianti A, Bello MG, Follador A, Sinaccio G, Pronzato P, Grossi F.
    Crit Rev Oncol Hematol; 2008 Dec; 68(3):183-96. PubMed ID: 18606548
    [Abstract] [Full Text] [Related]

  • 13. Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer.
    Blackhall FH, Shepherd FA.
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):1121-41, ix. PubMed ID: 15474338
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.
    Subramanian J, Morgensztern D, Govindan R.
    Clin Lung Cancer; 2010 Sep 01; 11(5):311-9. PubMed ID: 20837456
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [New strategies for NSCLC: is inhibition of tumour vasculature useful].
    Reinmuth N, Steins M, Kreuter M, Thomas M.
    Pneumologie; 2010 Jun 01; 64(6):376-86. PubMed ID: 20229453
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.